Histogenics appointed Stephen Kennedy as chief technology officer, effective immediately.
Here are four things to know:
1. Mr. Kennedy joined Histogenics in 2013 as senior vice president of technical operations.
2. Before that, he served as the executive vice president, research and development, at Mascoma, a biofuel company.
3. He has also held several senior leadership roles in technical operations at Genzyme, a biopharmaceutical company.
4. Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal market.